Synthon, MIVAC in MS deal

Synthon BV (Nijmegen, The Netherlands) partnered with MIVAC Development AB (Goteborg, Sweden) to research and develop multiple sclerosis (MS) candidates. The partners will use MIVAC's tolerance-induci...